Building CNS health and wellness using scientific approaches…
NeuroTheryX is a biotechnology company with research, discovery and development of pharmaceuticals and nutraceuticals
Pharmaceutical and nutraceutical products are identified and evaluated using genetic targets and phenotype-based models – emphasizing a biological and mechanistic approach.
Unique combination of highly predictive and efficient biology-driven models with a focused and prioritized chemistry approach defines the technology platform at NeuroTheryX.
The speed, fidelity, and predictability of the NeuroTheryX Technology Platform has allowed the company to establish a pipeline of Development Projects
Our Projects
-
Project 1.0
Small molecule oral formulation drugs for the therapeutic intervention of Primary Progressive Multiple Sclerosis.
-
Project 2.0
Artificial Intelligence and phenotype-based design of synthetic “new chemical entity” cannabinoids.
